Medical Devices
-
Prices rise at surgery centers acquired by Optum: study
The full financial impact of the price hikes could exceed $67 million each year in two dozen markets, according to the new study published in Health Affairs.
By Rebecca Pifer Parduhn • Feb. 4, 2026 -
J&J corrects Impella heart pumps over issue linked to 22 serious injuries
The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.
By Nick Paul Taylor • Feb. 4, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Genetic testing takes greater share of Medicare Part B test spending: OIG
Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.
By Susan Kelly • Feb. 4, 2026 -
Abbott receives FDA warning letter over Freestyle Libre CGMs
Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.
By Elise Reuter • Feb. 3, 2026 -
Medtronic to acquire CathWorks for up to $585M
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.
By Elise Reuter • Feb. 3, 2026 -
STAAR names interim co-CEOs amid search for permanent leader
The company is looking for a new top executive after former CEO Stephen Farrell left when STAAR shareholders rejected a buyout offer from Alcon.
By Nick Paul Taylor • Feb. 3, 2026 -
Beta Bionics receives FDA warning letter
The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute products, the company said.
By Elise Reuter • Feb. 2, 2026 -
Lawsuit challenges ethylene oxide exemptions for device sterilizers
The lawsuit questions the Trump administration’s authority to make sweeping environmental exemptions without evidence.
By Elise Reuter • Feb. 2, 2026 -
Stryker starts first cases with handheld ortho robot
Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.
By Elise Reuter • Jan. 30, 2026 -
Senseonics wins CE mark for one-year CGM
The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.
By Nick Paul Taylor • Jan. 30, 2026 -
Top medtech trends to watch in 2026
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.
By Ricky Zipp • Jan. 29, 2026 -
CDRH on track for review timelines despite staff cuts
The Center for Devices and Radiological Health said it is on track to meet review times specified by user fee agreements, despite “resource challenges.”
By Elise Reuter • Jan. 29, 2026 -
Medtech M&A took off in the second half of 2025: report
Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.
By Elise Reuter • Jan. 28, 2026 -
Edwards’ request for broader TAVR Medicare coverage gets pushback
Several medical societies supported extending Medicare coverage for TAVR to patients with asymptomatic aortic stenosis, but some physicians and rival Medtronic said more data is needed.
By Susan Kelly • Jan. 28, 2026 -
Medtronic targets ASCs with extended Mindray collaboration
Mindray is integrating Medtronic patient monitoring technologies into its platforms to meet the needs of ambulatory surgery centers.
By Nick Paul Taylor • Jan. 27, 2026 -
Deep Dive
5 robotic surgery trends to watch in 2026
Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.
By Susan Kelly • Jan. 27, 2026 -
FDA guidance eases wearables oversight. But experts have questions about what’s next.
Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will navigate a growing pool of wearables.
By Elise Reuter • Jan. 27, 2026 -
Medtronic wins CE mark for single-shot pulsed field ablation catheter
Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave catheter.
By Nick Paul Taylor • Jan. 26, 2026 -
Intuitive’s cardiac initiative includes valve repair, LAA closure
With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.
By Susan Kelly • Jan. 26, 2026 -
Intuitive pushes into cardiac robotic surgery, ASCs
The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.
By Susan Kelly • Jan. 23, 2026 -
Integra recalls wound and burn devices amid reports of serious injuries
Packaging failures could lead to breaches in the sterile barrier and patient infections.
By Nick Paul Taylor • Jan. 23, 2026 -
Abbott posts Q4 sales below expectations
Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.
By Elise Reuter • Jan. 22, 2026 -
AdvaMed leaders on tariffs, MDUFA and wearables
AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.
By Elise Reuter • Jan. 22, 2026 -
J&J’s cardiovascular business boosts medtech growth in 2025
Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.
By Ricky Zipp • Jan. 21, 2026 -
Retrieved from Anteris Technologies Global on January 21, 2026
Medtronic to buy up to $90M stake in heart valve developer Anteris
Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.
By Susan Kelly • Jan. 21, 2026